Helix logo in white and blue

Market Access Key Opinion Leaders (MAKOLs)

Refine your stakeholder engagement strategy and leverage Market Access Key Opinion Leader (MAKOL) expertise, influence and networks to drive evidence-based access and reimbursement strategies.

A VISFO "intelligence board" displaying elements of the "Market Access Key Opinion Leaders (MAKOLs)" offering displayed on both a desktop and mobile screen. The desktop view includes a visualization of a "Global MAKOL search", while the mobile screen view provides profile metrics, as well as regional MAKOL shortlists.

Definition

A recognized expert who regularly publishes on market access themes, such as disease burden, treatment cost-effectiveness and reimbursement challenges, within a specific therapeutic area.

Criteria

Demonstrates a strong publication record in peer-reviewed journals, publishing on themes such as: unmet needs; disease and economic burden; cost-effectiveness and budget impact of current and emerging therapies; healthcare resource utilization; reimbursement and access challenges

Consistently authors systematic reviews, guidelines, or meta-analyses

A well-respected researcher, clinician, economist or health policy expert

Involved in country-specific or regional policy development and health economics initiatives

Power your decision-making

with bespoke and intuitive intelligence boards

VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in an agile, always-on delivery portal, you can quickly:

Visualize

Identify

Interrogate integrated and enriched data from diverse sources to identify MAKOLs in your therapy area and markets of interest. Our analyses typically span 10 years, meaning we can help you accurately identify and geolocate thousands of thought leaders in your field.

A VISFO "intelligence board" displaying elements of the "Market Access Key Opinion Leaders (MAKOLs)" offering displayed on both a desktop and mobile screen. The desktop view includes a visualization of a "Global MAKOL search", while the mobile screen view provides profile metrics, as well as regional MAKOL shortlists.

Analyze

Confidently inform your engagement strategy by using sophisticated data analytics tools to:

Reveal MAKOL publication histories

  • Develop a holistic understanding of each individual MAKOL’s expertise and areas of special interest using up to date bibliometrics alongside a relevant literature library for each individual.
  • Gain in-depth knowledge of the latest trends, methodologies and evidence in market access research, alongside the factors that impact the adoption and reimbursement of therapies.

Map MAKOL geolocation and professional networks

  • Inform territorial lines, facilitate clinical trial recruitment, and tailor communications to priorities relevant to specific MAKOLs by determining their geolocation.
  • Understand information flow and locate hubs of expertise by identifying publication co-authors and mapping collaboration networks across specialties and locations (at institute, city, state, country and global level).

Understand individual MAKOL impact

  • Leverage our proprietary KOL impact factors based on publication volume, currency, and authorship weight, to identify MAKOLs whose expertise and experience aligns most closely with your company’s specific needs and strategic imperatives.
  • Select additional metrics including journal prestige, publication type, and co-author impact factor to further interrogate individual influence in your chosen topic area.
  • Track impact factors longitudinally to indicate changes in activity over time.

Connect with digital leaders

  • Use social listening outputs to identify digitally active MAKOLs who leverage online platforms to maximize reach and impact.

Maintain a clear view of the MAKOL landscape throughout the lifecycle of your product with user-defined data updates.

Use cases

Empower market access teams to create compelling value propositions that align with payer priorities

Develop evidence-based market access and reimbursement strategies

Build awareness of, and support for, your product among key stakeholders

Identify and target patient subgroups with the highest unmet need

Guide drug development strategies and clinical trial design to incorporate endpoints relevant to market access, such as quality of life, healthcare resource utilization and cost-effectiveness

Define value drivers for your therapeutic area early, to anticipate payer requirements for clinical evidence

Encourage collaboration between Medical Affairs teams and MAKOLs to facilitate understanding and communication of your therapy’s value to healthcare providers and other stakeholders

Partner with MAKOLs to co-author peer-reviewed publications and participate in advisory boards to highlight emerging trends and therapies

Guide post-approval studies

Delivered through Helix

Modular knowledge base

  • Interactive data visualizations for easy self-serve analysis and insight surfacing

  • Comprehensive opinion leader profiles for effective interaction planning and engagement

  • Multiple data export options for rapid insight sharing across your business

  • Customizable, modular knowledge bases with no user limits

A VISFO "intelligence board" showing elements of the Key Opinion Leader (KOL) mapping service offering displayed on both a desktop and mobile screen. Included are visualizations of a "Global KOL search", and a "KOL influence analysis".